Breaking News on Supplements, Health & Nutrition - Europe US edition | APAC edition

Trends > Omega-3

Maternal omega-3 supplements reduce preterm birth risk: Study

By Nathan Gray+

Last updated on 26-Feb-2013 at 14:40 GMT2013-02-26T14:40:52Z

Maternal omega-3 supplements reduce preterm birth risk: Study

Prenatal supplementation with the omega-3 fatty acid DHA may help to cut the risk of preterm and low birth weight babies, says new study data.

Mothers given 600 milligrams of docosahexaenoic acid (DHA) throughout pregnancy had babies that were less likely to be very low birth weight and born before 34 weeks gestation than infants of mothers who were given a placebo, according to the findings of a new clinical trial published in the American Journal of Clinical Nutrition.

The US-based researchers behind the study said their findings greatly strengthen the case for using dietary supplementation of DHA during pregnancy.

"A reduction in early preterm and very low birth weight delivery could have clear clinical and public health significance," said Professor Susan Carlson from the University of Kansas – who directed the study.

Carlson commented that she believes supplementing with DHA could safely increase birth weight and gestational age in many countries to numbers that are close to countries such as Norway and Australia.

Study details

The study results are from the first five years of a 10-year, double-blind randomised controlled trial.

In the trial 350 women were randomised to consume either 600mg DHA or placebo supplements  from before the 20th week of gestation to birth.

The DHA supplementation resulted in higher maternal and cord blood-phospholipid-levels of DHA, a longer gestation duration, and greater birth weight, length and head circumference, said the researchers.

“In addition, the DHA group had fewer infants born at <34 wk of gestation and shorter hospital stays for infants born preterm than did the placebo group.”

Follow-up study

Carlson and her team added that a follow-up of this sample of infants is currently ongoing, and aims to determine whether prenatal DHA nutritional supplementation will benefit children's intelligence and school readiness.

Children of women enrolled in the study received multiple developmental assessments at regular intervals throughout infancy and at 18 months of age. In the next phase of the study, the children will receive twice-yearly assessments until they are 6 years old.

The team plan to assess developmental milestones that occur in later childhood and are linked to lifelong health and welfare.

Previous research has established the effects of postnatal feeding of DHA on infant cognitive and intellectual development, but DHA is accumulated most rapidly in the foetal brain during pregnancy, said Colombo.

"That's why we are so interested in the effects of DHA taken prenatally, because we will really be able to see how this nutrient affects development over the long term."

Source: American Journal of Clinical Nutrition
Published online ahead of print, doi: 10.3945/​ajcn.112.050021
"DHA supplementation and pregnancy outcomes"
Authors: Susan E Carlson, John Colombo, Byron J Gajewski,Kathleen M Gustafson, David Mundy,

Related products

Live Supplier Webinars

Polyphenols tipped to become the way to innovate in Sports Nutrition
Alpha & Omega in Sports Nutrition – Using Omega 3’s and A-GPC to improve performance and recovery.
KD Pharma
Orally bioavailable standardized botanical derivatives in sport nutrition: special focus on recovery in post-intense physical activities
Collagen in motion: move freely and keep your injuries in check
Leading manufacturer of gelatine and collagen peptides
Life’s too short for slow proteins. Whey proteins hydrolysates: Fast delivery for enhanced performance
Arla Foods Ingredients
What it Takes to Compete and Win in Today’s Sports Nutrition Market
Sports Nutrition Snapshot: Key regional drivers and delivery format innovations
William Reed Business Media
Gutsy performance: How can microbiome modulation help athletes and weekend warriors
William Reed Business Media
Pushing the boundaries: Where’s the line between ‘cutting edge nutrition’ and doping
William Reed Business Media

On demand Supplier Webinars

High-amylose maize starch may reduce the risk of type 2 diabetes: what does this qualified health claim mean?
Balancing Innovation and Risk in Sports Nutrition Ingredients
Explaining bio-hacking: is there a marketing opportunity for food companies?
William Reed Business Media
Personalized Nutrition – how an industry can take part in shaping the future of Nutrition
BASF Nutrition & Health
Find out Nutritional and ingredient lifecycle solutions and strategies!
Is the time rIpe for I-nutrition?
William Reed Business Media
The Advantage of Outsourcing Fermentation-based Manufacturing Processes
Evonik Health Care
All supplier webinars